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Background: Radiation exposure can lead to detrimental effects in skin microcirculation.
The precise relationship between radiation dose received and its effect on cutaneous per-
fusion still remains controversial. Previously, we have shown that hyperspectral imaging
(HSI) is able to demonstrate long-term reductions in cutaneous perfusion secondary to
chronic microvascular injury. This study characterizes the changes in skin microcirculation
in response to varying doses of ionizing radiation and investigates these microcirculatory
changes as a possible early non-invasive biomarker that may correlate with the extent of
long-term microvascular damage.
Methods: Immunocompetent hairless mice (n=66) were exposed to single fractions
of superficial beta-irradiation in doses of 0, 5, 10, 20, 35, or 50Gy. A HSI device was
utilized to measure deoxygenated hemoglobin levels in irradiated and control areas.
HSI measurements were performed at baseline before radiation exposure and for the
first 3 days post-irradiation. Maximum macroscopic skin reactions were graded, and
histological assessment of cutaneous microvascular densities at 4weeks post-irradiation
was performed in harvested tissue by CD31 immunohistochemistry.
Results: CD31 immunohistochemistry demonstrated a significant correlation (r=0.90,
p<0.0001) between dose and vessel density reduction at 4weeks. Using HSI analysis,
early changes in deoxygenated hemoglobin levels were observed during the first 3 days
post-irradiation in all groups. These deoxygenated hemoglobin changes varied propor-
tionally with dose (r=0.98, p<0.0001) and skin reactions (r=0.98, p<0.0001). There
was a highly significant correlation (r=0.91, p<0.0001) between these early changes
in deoxygenated hemoglobin and late vascular injury severity assessed at the end of
4weeks.
Conclusion: Radiation dose is directly correlated with cutaneous microvascular injury
severity at 4weeks in our model. Early post-exposure measurement of cutaneous deoxy-
genated hemoglobin levels may be a useful biomarker for radiation dose reconstruction
and predictor for chronic microvascular injury.
Keywords: hyperspectral imaging, diffuse reflectance imaging, microcirculatory damage, radiation exposure,
radiation dosage, radiation effects, perfusion imaging
Frontiers in Oncology | www.frontiersin.org October 2015 | Volume 5 | Article 2321
Chin et al. Biomarker for radiation exposure and skin damage
BACKGROUND
Exposure to ionizing radiation can have profound biological con-
sequences. Scenarios for radiation exposure range from exter-
nal beam radiotherapy for oncologic treatment to uncontrolled
release events such as a nuclear attack or accident. The disasters
at Fukushima and Chernobyl emphasize the real possibility of the
latter scenario. Cutaneous skin reactions in response to ionizing
radiation exposure are major consequences in both cases. These
skin reactions in the acute phase can range from mild skin ery-
thema to ulceration. For radiotherapy alone, it has been reported
that amajority of patients receiving radiotherapy experience some
degree of acute skin reaction (1).
The precise etiology of ionizing radiation-induced skin injury
remains unclear. Multiple theories proposed include direct cel-
lular injury, cell signaling dysregulation, and ischemia (2–4).
Recently, the literature has suggested that cutaneous ischemia
may be the predominant characteristic that links both acute and
chronic-phase injuries (5, 6). However, these studies have all been
limited as they use only a single large dose of ionizing radiation.
In our laboratory, we have established a reliable model of
radiation-induced skin injury using a hairless mouse and a single
fixed-dose of surface beta-irradiation (7, 8). Using hyperspec-
tral imaging (HSI) technology, we have identified characteristic
changes in cutaneous perfusion that are reproducible in magni-
tude and in timing, preceding the visible appearance of skin injury,
and corresponding to the degradation of the dermal vascular
density.
Two significant issues remain unaddressed: (1) the relationship
between the dose of cutaneous irradiation and the magnitude
of cutaneous perfusion changes observed over time and (2) the
relationship between early cutaneous perfusion changes and the
development of acute or chronic skin injury post-irradiation. A
better understanding of the latter may have significant clinical
application since the development of acute skin reactions during
radiotherapy may necessitate a treatment break. It has been esti-
mated that a treatment break of more than a week during breast
cancer radiotherapy can negatively impact recurrence rate and
overall survival (9, 10). Therefore, the ability to detect and predict
high-risk areas for developing skin damage and individualize
the treatment plan accordingly may prevent the need for these
detrimental treatment breaks.
MATERIALS AND METHODS
Animals and Irradiation Procedure
All handling of and procedures performed with animals were
done in accordance with a protocol (UMass IACUC Protocol
#A2354) approved by our Institutional Animal Care and Use
Committee. Prior to this experiment, we established a model
of acute radiation-induced skin injury (7). The radiation source
utilized was a Strontium-90 beta-emitter with an active diameter
of 9mm, which created an 8mm diameter skin injury. This beta-
emitter source delivered less than 10% of the total dose deeper
than 3.6mm into the skin, avoiding injury to internal organs.
Hairless, immunocompetent adult mice (SKH-1 Elite, Charles
River Laboratories, Wilmington, MA, USA) were used. Mice
(n= 66) were equally divided into six groups of eleven mice each.
Each group received one of six pre-specified doses of ionizing
radiation respectively: 0, 5, 10, 20, 35, and 50Gy.
On day 0, mice were anesthetized. Tattooing was performed
bilaterally on the dorsal flank skin of the mice to act as fiducial
marks. Cutaneous perfusion was assessed using HSI prior to irra-
diation as described below. This pre-irradiation assessment served
as a baseline level for subsequent comparison. Mice then received
a single pre-specified dose of irradiation as described above. Accu-
rate dose-delivery was ensured prior to animal irradiation using
radiochromic film dosimetry. Following irradiation, mice were
recovered and housed individually.
Hyperspectral Imaging for Evaluation of
Cutaneous Perfusion
Evaluation of cutaneous perfusionwas accomplished using a novel
application of an existing technology, HSI. HSI is a method of
wide-field diffuse reflectance spectroscopy that utilizes a spectral
separator to vary the wavelength of light entering a digital camera
and provides a diffuse reflectance spectrum for every pixel. These
spectra are then compared to standard transmission solutions
to calculate the concentration of deoxy-hemoglobin (DeoxyHb)
in each pixel, from which spatial maps of these parameters are
constructed.
Using HSI, cutaneous perfusion was analyzed over the first
3 days after radiation exposure. During this time, HSI measure-
ments were performed in all groups, once daily per mouse, for
a total of 198 image acquisitions. Skin reactions were then eval-
uated twice weekly for the first 14 days and then weekly through
28 days post-irradiation. At the time of each evaluation, mice were
anesthetized and maintained at standard body temperature. The
OxyVu-2 device (HyperMed, Greenwich, CT, USA) was utilized
for HSI acquisitions. The OxyVu-2-generated spatial maps of tis-
sueDeoxyHbwere used for quantification of cutaneous perfusion.
These maps were analyzed with MATLAB R2010b (Mathworks
Inc., Natick, MA, USA). Mean values of DeoxyHb were calculated
for a 79-pixel area corresponding to the irradiated area on each
flank. This 79-pixel area was determined precisely over time with
reference to the fiducial tattoo marks that were placed prior to
irradiation.
Similarly, areas of non-irradiated contralateral flank skin were
quantified to ensure that any changes in perfusion observed in
the irradiated skin were not due to natural variations or systemic
phenomena.
Values for DeoxyHb parameters for post-irradiation time
points are expressed as relative to pre-irradiation values within the
same area of skin. Mean relative values reported hereafter reflect
the average of relative levels for all subjects within a dose group at
a specified time point.
Post-Irradiation Tissue Analysis
On day 28 post-irradiation, mice were euthanized following
cutaneous perfusion assessment. Immediately post-mortem,
irradiated and non-irradiated skin from both flanks was
harvested. Tissue was fixed en bloc in 10% neutral-buffered
formalin solution and kept at 4°C overnight for paraffin embed-
ment. Paraffin-embedded sections were re-hydrated though a
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decreasing alcohol series and stained for vasculature as described
previously (8). Primary antibody (PECAM-1) for vasculature
staining (BD Pharmingen, San Jose, CA, USA) was incubated at
4°C overnight. Signals were intensified by using a tyramide ampli-
fication system (PerkinElmer, Boston, MA, USA) and activated
with DAB Chromogen (Dako North America Inc., Carpinteria,
CA, USA). Slides were counterstained with hematoxylin.
Digital images were obtained from the center of all stained skin
sections at 10magnification with anOlympus BX53microscope
(Olympus America Inc., Center Valley, PA, USA). Two-blinded
reviewers quantified vessel density using three random standard-
sized fields and results were averaged. Vessel densities for each
animal were expressed as a ratio between the irradiated sample
and its respective contralateral non-irradiated internal control,
yielding normalized mean vessel densities.
Statistical Analysis
For hyperspectral data, plots of perfusion data are expressed as
the relativemean unless otherwise specified. Changes inDeoxyHb
and dose were correlated with cutaneous blood vessel densi-
ties using linear regression models. Statistical significance was
assumed for p values <0.05.
RESULTS
Macroscopic Skin Reaction
Mice were irradiated as previously described without complica-
tion. Mice gained weight appropriately following irradiation and
no morbidity or mortality was observed. Skin reactions began
forming in all groups by approximately 1week post-irradiation.
Maximal skin reactions were observed by day 14 in all groups
and scored using the Radiation Therapy Oncology Group toxicity
scoring system, which describes skin reactions from erythema to
ulceration over a four-point scale (11). Maximal skin reactions
were observed to be characterized by erythema in the 5 and 10Gy
groups. Dry desquamation was observed as the maximal skin
reaction of mice receiving 20 and 35Gy. In the 50Gy group, moist
desquamation was observed in all irradiated areas (Table 1).
Changes in Microvascular Density
A pronounced reduction in cutaneous vascular densities at
4 weeks following irradiation was observed. CD31 immuno-
histochemistry demonstrated an inverse correlation (r= 0.90,
p< 0.0001) between dose and vessel reduction severity, with
vessel counts decreasing as the dose increased (Figure 1).
Relationship of Early Deoxygenated
Hemoglobin Changes and Radiation Dose
Using HSI analysis, early changes in deoxygenated hemoglobin
levels were observed during the first 3 days post-irradiation in all
groups. An acute decrease in deoxygenated hemoglobin was seen
TABLE 1 |Maximal skin reaction scores (0–4) at 14days post-irradiation.
Dose (Gy) 0 5 10 20 35 50
Skin reaction 0 (11) 1 (11) 1 (11) 2 (11) 2 (11) 3 (11)
for each dose over the first 3 days before any visible skin reactions
were observed (Figure 2). When further examining the behavior
of deoxygenated hemoglobin over the first 3 days, it was noted that
the slope changed linearly with increasing radiation dose exposure
(r= 0.98, p< 0.0001) (Figure 3).
Correlation between Early Deoxygenated
Hemoglobin Changes and Microvascular
Density
Using the relationships between early DeoxyHb changes with
dose, we could also observe that deoxygenated hemoglobin
decrease at 3 days had a strong linear association with microvas-
cular density by 4weeks for the given doses, indicating that early
deoxygenated hemoglobin response could be predictive of final
degree of microvascular damage. There was a highly significant
correlation (r= 0.91, p< 0.0001) between these early changes
in deoxygenated hemoglobin and late vascular injury severity
assessed (Figure 4).
Relationship between Early Deoxygenated
Hemoglobin Changes and Skin Reaction
In addition, when examining the relationship between deoxy-
genated slope change in the first 3 days and maximal skin reac-
tion at 14 days, there was a strong linear correlation (r= 0.98,
p< 0.0001) (Figure 5). This suggests that early decreases seen dur-
ing serial assessment of deoxygenated hemoglobin may be related
to the degree of maximal skin reaction after radiation exposure.
DISCUSSION
Exposure to ionizing radiation is known to induce the expression
of numerous vasoactive mediators (12), as well as directly injure
the cutaneous microvasculature (2). These effects have the likely
consequence of altering cutaneous perfusion. However, little is
known about the relationship between the degree of alteration
in cutaneous perfusion following exposure and the varying doses
of ionizing radiation received. This study was designed to bet-
ter characterize changes in microcirculation over wide range of
superficial radiation exposure.
This project highlights our ability to accurately deliver varying
doses of ionizing radiation to the superficial soft tissues using our
established model (7, 8). We were able to achieve reproducible
results with no off-target morbidity, per previous investigations.
The delivery of doses of a much smaller magnitude than our
previously described 50Gy dose allows us to further investi-
gate the effects of fractionated irradiation schemes on cutaneous
perfusion. This will be particularly important in translating our
work closer toward a model that reflects the low dose fraction-
ation schemes currently employed in therapeutic external beam
radiation.
Our previous studies have demonstrated that HSI can be used
to analyze acute changes in perfusion and oxygenation in the
first week after exposure to radiation. In particular, our initial
study suggested a sharp decline in deoxy-hemoglobin within
the first several days (7). The current study elaborates on these
findings suggesting that increasing radiation doses correlate to
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FIGURE 1 | On left, examples of CD31 staining in skin exposed to 50Gy (top) and unirradiated (bottom). On right, relative vessel density at 4weeks after
radiation dose demonstrated an inverse linear relationship with initial radiation dose exposure (r=0.90, p<0.0001).
FIGURE 2 | Relative deoxy-hemoglobin changes decreased over the
first 3 days for each level of radiation exposure. Note the increasing rate
of change as the radiation dose becomes larger.
deoxygenated hemoglobin response. This phenomenon may be
explained by the acute vasoactive effects of radiation, as previous
work has shown increased vascular permeability after exposure
to increasing amounts of radiation. Krishnan et al. demonstrated
using a radiolabeled technique that albumin extravasation into
the interstitial space was dose-related (13, 14). In line with these
findings, our observed changes in intravascular deoxygenated
hemoglobin using HSI may be a result of this dose-dependent
phenomenon, making this study the first to demonstrate a non-
invasive biomarker of radiation.
Detection of radiation exposure or injury by rapid and non-
invasive means is currently unavailable. To date, numerous strate-
gies that minimize time and invasiveness have been proposed to
perform biodosimetry. Some of these strategies include utilization
FIGURE 3 | Deoxy-hemoglobin trend over the first 3 days for each dose
level revealed a strong linear relationship (r =0.98, p<0.0001). As this
plot was derived from the average slope of each dose group depicted in
Figure 2 (total n=66), SDs were not plotted.
of serum biomarkers, and currently, the gold standard for detec-
tion of radiation exposure is chromosomal analysis (15). However,
since chromosomal analysis requires venipuncture and need for a
laboratory setting to process samples, it is unable to provide point-
of-care results for triage or treatment guidance. Serumbiomarkers
present an opportunity to correct some of these shortcomings by
allowing for potential point-of-care testing without the need for a
laboratory setting (16). However, at present, there are no validated
serum biomarkers in clinical use that provide sensitive and spe-
cific assessments of radiation exposure and biodosimetry despite
numerous potential targets being identified (17–23). In addition,
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FIGURE 4 | The final 4-week relative vessel density demonstrated a
strong inverse relationship with initial 3-day deoxy-hemoglobin slope
for each radiation dose (r =0.91, p<0.0001).
FIGURE 5 |Maximal skin reaction score by day 14 was strongly
correlated to the initial three day deoxy-hemoglobin slope for each
radiation dose (r =0.98, p<0.0001). There were no SDs of the skin reaction
scores plotted as there was no categorical variation within each group (total
n= 66) as illustrated in Table 1.
serum biomarkers are still invasive, requiring venipuncture. Non-
invasive monitoring of deoxygenated hemoglobin may provide a
fast and reliable method for biodosimetry and post-exposure dose
reconstruction.
Other studies focused primarily on isotope flow markers to
measure the extent microvascular change, demonstrated that
exposures varied according to dose. However, no studies histo-
logically examined vessel density correlation with dose exposure
(13, 14, 24, 25).
The current study demonstrated that over a large exposure
gradient, the initial radiation dose appears to be directly correlated
to the degree of microvascular injury. This finding is consistent
with results by Haubener et al. who showed that varying doses
of single fraction radiation exposure had an increasing effect on
diminishing endothelial cell number in vitro (26).
Furthermore, we found that a strong relationship exists
between deoxygenated hemoglobin response and final vessel den-
sity after radiation exposure. This suggests the possibility of using
early monitoring of deoxygenated hemoglobin for prediction of
chronic vascular damage.
In parallel, our results also suggest that deoxygenated
hemoglobin response may be related to formation of acute skin
reaction seen weeks after initial radiation exposure. No previous
studies have been able to identify a biomarker that predicts the
formation of an adverse skin reaction after exposure to radiation.
If supported by clinical studies, applications of this finding could
result in improved skin monitoring of patients receiving both
therapeutic and diagnostic radiologic procedures. Currently, the
development of acute skin reactions during radiotherapy usually
signals a treatment break. It has been estimated that a treatment
break of a more than a week during breast cancer radiotherapy
can negatively impact recurrence rate and overall survival (9,
10). Therefore, the ability to detect and predict high-risk areas
or high-risk patients for developing skin reactions earlier and
change the treatment plan accordingly, may prevent the need for
these detrimental treatment breaks.
The current feasibility study suggests that changes in
hemoglobin may be assessed in stereotactic body radiosurgery
procedures where a single fraction of high dose (30Gy or higher)
may be used in radiation treatment (27, 28). Single high dose
radiation exposures may also occur during fluoroscopically
guided procedures. Patients undergoing these procedures
can receive relatively high radiation doses, which have been
documented as resulting in acute and chronic skin injury (29).
One major limitation of the current study is the inability to
make any clinical inferences regarding deoxygenated hemoglobin
response after multiple fractions of radiation that are seen inmore
traditional oncologic radiation therapy. We are actively pursuing
this clinical research in fractionated therapy, and preliminary
data has indicated radiation dose can be predicted through a
mathematical model using HSI as a metric.
CONCLUSION
The current study suggests that early measurement of cutaneous
deoxygenated hemoglobin levels after radiation exposure may be
a useful biomarker for dose reconstruction and also for chronic
microvascular injury. Changes in deoxygenated hemoglobin may
also be correlated to acute skin reactions before any are visible.
Clinical studies are needed to validate the relationship between
early changes in cutaneous circulation following irradiation and
subsequent injury development.
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